146 related articles for article (PubMed ID: 33462716)
21. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
[TBL] [Abstract][Full Text] [Related]
22. The current clinical value of the DCIS Score.
Wood WC; Alvarado M; Buchholz DJ; Hyams D; Hwang S; Manders J; Park C; Solin LJ; White J; Willey S
Oncology (Williston Park); 2014 May; 28 Suppl 2():C2, 1-8, C3. PubMed ID: 25375000
[TBL] [Abstract][Full Text] [Related]
23. Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan.
Yotsumoto D; Sagara Y; Kumamaru H; Niikura N; Miyata H; Kanbayashi C; Tsuda H; Yamamoto Y; Aogi K; Kubo M; Tamura K; Hayashi N; Miyashita M; Kadoya T; Saji S; Toi M; Imoto S; Jinno H
Breast Cancer; 2022 Jan; 29(1):1-8. PubMed ID: 34665435
[TBL] [Abstract][Full Text] [Related]
24. Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy.
Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Gu S; Fong C; Tuck A; Youngson B; Miller N; Done SJ; Chang MC; Sengupta S; Elavathil L; Jani PA; Bonin M; Lalani N; Paszat L
Breast; 2018 Feb; 37():181-186. PubMed ID: 28781102
[TBL] [Abstract][Full Text] [Related]
25. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
[TBL] [Abstract][Full Text] [Related]
26. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.
Parikh P; Pockaj B; Wasif N; Halyard M; Wong W; Kosiorek HE; Dueck AC; Gray R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S516-21. PubMed ID: 25986869
[TBL] [Abstract][Full Text] [Related]
27. Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCIS.
Paszat L; Sutradhar R; Zhou L; Nofech-Mozes S; Rakovitch E
Clin Breast Cancer; 2019 Feb; 19(1):35-46. PubMed ID: 30190195
[TBL] [Abstract][Full Text] [Related]
28. Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.
Rakovitch E; Sutradhar R; Lalani N; Nofech-Mozes S; Gu S; Goldberg M; Hanna W; Fong C; Paszat L
Breast Cancer Res Treat; 2019 Nov; 178(1):169-176. PubMed ID: 31325071
[TBL] [Abstract][Full Text] [Related]
29. Contemporary treatment of ductal carcinoma in situ of the breast.
Mokbel K
Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
[TBL] [Abstract][Full Text] [Related]
30. Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort.
Sprague BL; Vacek PM; Herschorn SD; James TA; Geller BM; Trentham-Dietz A; Stein JL; Weaver DL
Breast Cancer Res Treat; 2019 Feb; 174(1):227-235. PubMed ID: 30448897
[TBL] [Abstract][Full Text] [Related]
31. Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.
Rakovitch E; Gray R; Baehner FL; Sutradhar R; Crager M; Gu S; Nofech-Mozes S; Badve SS; Hanna W; Hughes LL; Wood WC; Davidson NE; Paszat L; Shak S; Sparano JA; Solin LJ
Breast Cancer Res Treat; 2018 Jun; 169(2):359-369. PubMed ID: 29388015
[TBL] [Abstract][Full Text] [Related]
32. Ductal carcinoma in situ: a disease entity that merits more recognition.
Dereere E; Papadimitriou K; Tjalma W; Altintas S
Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
[TBL] [Abstract][Full Text] [Related]
33. Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.
Gennaro M; De Santis MC; Mariani L; Lo Vullo S; Cappelletti V; Agresti R; Cortinovis U; Paolini B; Di Cosimo S; Carcangiu ML; Daidone MG; Lozza L
Breast; 2017 Oct; 35():63-68. PubMed ID: 28651115
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic strategy for ductal carcinoma in situ patients according to Van Nuys Prognostic Index.
Andretta M; Scomersi S; Urbani M; Bortul M
Ann Ital Chir; 2014; 85(3):254-9. PubMed ID: 25074533
[TBL] [Abstract][Full Text] [Related]
35. Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conserving Surgery Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study.
de Sousa CFPM; Pereira AAL; Arruda GV; Gouveia AG; Hanna SA; Cruz MRS; Dos Anjos CH; Bevilacqua JLB; Alcantara Filho P; de Moraes FY; Marta GN
Clin Breast Cancer; 2023 Dec; 23(8):e499-e506. PubMed ID: 37758557
[TBL] [Abstract][Full Text] [Related]
36. The time-varying effect of radiotherapy after breast-conserving surgery for DCIS.
Rakovitch E; Sutradhar R; Hallett M; Thompson AM; Gu S; Dumeaux V; Whelan TJ; Paszat L
Breast Cancer Res Treat; 2019 Nov; 178(1):221-230. PubMed ID: 31368035
[TBL] [Abstract][Full Text] [Related]
37. Selective use of whole breast radiotherapy after breast conserving surgery for invasive breast cancer and DCIS.
Skandarajah AR; Bruce Mann G
Surgeon; 2013 Oct; 11(5):278-85. PubMed ID: 23632044
[TBL] [Abstract][Full Text] [Related]
38. Trends in the treatment of ductal carcinoma in situ of the breast.
Baxter NN; Virnig BA; Durham SB; Tuttle TM
J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
[TBL] [Abstract][Full Text] [Related]
39. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Rakovitch E; Nofech-Mozes S; Hanna W; Baehner FL; Saskin R; Butler SM; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Robertson SJ; Slodkowska E; Fong C; Anderson JM; Jamshidian F; Miller DP; Cherbavaz DB; Shak S; Paszat L
Breast Cancer Res Treat; 2015 Jul; 152(2):389-98. PubMed ID: 26119102
[TBL] [Abstract][Full Text] [Related]
40. Impact of hormonal status on ductal carcinoma in situ of the breast: Outcome and prognostic factors.
Tay THC; Ng WY; Ong KW; Wong CY; Tan BKT; Yong WS; Madhukumar P; Tan VKM; Lim SZ; Sim Y
Breast J; 2020 May; 26(5):937-945. PubMed ID: 31876337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
